IRIS Accounts Production v22.1.4.3 SC261160 Board of Directors 1.4.21 31.3.22 31.3.22 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2611602021-03-31SC2611602022-03-31SC2611602021-04-012022-03-31SC2611602020-03-31SC2611602020-04-012021-03-31SC2611602021-03-31SC261160ns16:Scotland2021-04-012022-03-31SC261160ns15:PoundSterling2021-04-012022-03-31SC261160ns11:Director12021-04-012022-03-31SC261160ns11:PrivateLimitedCompanyLtd2021-04-012022-03-31SC261160ns11:SmallEntities2021-04-012022-03-31SC261160ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-31SC261160ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-31SC261160ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-31SC261160ns11:FullAccounts2021-04-012022-03-31SC261160ns11:OrdinaryShareClass12021-04-012022-03-31SC261160ns11:Director22021-04-012022-03-31SC261160ns11:CompanySecretary12021-04-012022-03-31SC261160ns11:RegisteredOffice2021-04-012022-03-31SC261160ns6:CurrentFinancialInstruments2022-03-31SC261160ns6:CurrentFinancialInstruments2021-03-31SC261160ns6:ShareCapital2022-03-31SC261160ns6:ShareCapital2021-03-31SC261160ns6:FurtherSpecificReserve3ComponentTotalEquity2022-03-31SC261160ns6:FurtherSpecificReserve3ComponentTotalEquity2021-03-31SC261160ns6:RetainedEarningsAccumulatedLosses2022-03-31SC261160ns6:RetainedEarningsAccumulatedLosses2021-03-31SC261160ns6:ShortLeaseholdAssetsns6:LandBuildings2021-04-012022-03-31SC261160ns6:ComputerEquipment2021-04-012022-03-31SC261160ns6:ShortLeaseholdAssetsns6:LandBuildings2021-03-31SC261160ns6:ComputerEquipment2021-03-31SC261160ns6:ShortLeaseholdAssetsns6:LandBuildings2022-03-31SC261160ns6:ComputerEquipment2022-03-31SC261160ns6:ShortLeaseholdAssetsns6:LandBuildings2021-03-31SC261160ns6:ComputerEquipment2021-03-31SC261160ns6:DeferredTaxation2021-03-31SC261160ns6:DeferredTaxation2022-03-31SC261160ns11:OrdinaryShareClass12022-03-31SC261160ns6:RetainedEarningsAccumulatedLosses2021-03-31SC261160ns6:FurtherSpecificReserve3ComponentTotalEquity2021-03-31SC261160ns6:RetainedEarningsAccumulatedLosses2021-04-012022-03-31
REGISTERED NUMBER: SC261160 (Scotland)















Unaudited Financial Statements for the Year Ended 31 March 2022

for

A & S Medical Services Ltd

A & S Medical Services Ltd (Registered number: SC261160)






Contents of the Financial Statements
for the Year Ended 31 March 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A & S Medical Services Ltd

Company Information
for the Year Ended 31 March 2022







DIRECTORS: Dr Jagdeep Luthra
Mrs Rekha Luthra





SECRETARY: Dr Jagdeep Luthra





REGISTERED OFFICE: c/o Dr Jagdeep Luthra
41 Craw Road
Paisley
Renfrewshire
PA2 6AD





REGISTERED NUMBER: SC261160 (Scotland)





ACCOUNTANTS: Stevenson & Kyles
Chartered Accountants
25 Sandyford Place
Glasgow
G3 7NG

A & S Medical Services Ltd (Registered number: SC261160)

Balance Sheet
31 March 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 225,187 210,082

CURRENT ASSETS
Cash at bank 19,325 9,191

CREDITORS
Amounts falling due within one year 5 127,599 83,917
NET CURRENT LIABILITIES (108,274 ) (74,726 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

116,913

135,356

PROVISIONS FOR LIABILITIES 6 8,932 6,082
NET ASSETS 107,981 129,274

CAPITAL AND RESERVES
Called up share capital 7 2 2
Fair value reserve 8 65,341 53,191
Retained earnings 8 42,638 76,081
SHAREHOLDERS' FUNDS 107,981 129,274

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A & S Medical Services Ltd (Registered number: SC261160)

Balance Sheet - continued
31 March 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 August 2022 and were signed on its behalf by:





Dr Jagdeep Luthra - Director


A & S Medical Services Ltd (Registered number: SC261160)

Notes to the Financial Statements
for the Year Ended 31 March 2022

1. STATUTORY INFORMATION

A & S Medical Services Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Investment property - not provided
Computer equipment - 25% on reducing balance

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

A & S Medical Services Ltd (Registered number: SC261160)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

2. ACCOUNTING POLICIES - continued

Grant income
Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

4. TANGIBLE FIXED ASSETS
Investment Computer
property equipment Totals
£    £    £   
COST OR VALUATION
At 1 April 2021 210,000 2,522 212,522
Additions - 168 168
Revaluations 15,000 - 15,000
At 31 March 2022 225,000 2,690 227,690
DEPRECIATION
At 1 April 2021 - 2,440 2,440
Charge for year - 63 63
At 31 March 2022 - 2,503 2,503
NET BOOK VALUE
At 31 March 2022 225,000 187 225,187
At 31 March 2021 210,000 82 210,082

Cost or valuation at 31 March 2022 is represented by:

Investment Computer
property equipment Totals
£    £    £   
Valuation in 2022 225,000 - 225,000
Cost - 2,690 2,690
225,000 2,690 227,690

The market values of the investment properties have been arrived at on the basis of a valuation carried out by the directors of the company who are not professionally qualified valuers. The
valuation was arrived at by reference to market evidence of transaction prices for similar properties in their location and takes into account the state of the rental market in the areas where the properties are situated.

A & S Medical Services Ltd (Registered number: SC261160)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Taxation and social security 1,982 2,379
Other creditors 125,617 81,538
127,599 83,917

6. PROVISIONS FOR LIABILITIES
2022 2021
£    £   
Deferred tax 8,932 6,082

Deferred
tax
£   
Balance at 1 April 2021 6,082
Tax on revaluation 2,850
Balance at 31 March 2022 8,932

7. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2022 2021
value: £    £   
2 Ordinary £1 2 2

8. RESERVES
Fair
Retained value
earnings reserve Totals
£    £    £   

At 1 April 2021 76,081 53,191 129,272
Profit for the year 23,557 23,557
Dividends (42,000 ) (42,000 )
Revaluation in year (15,000 ) 12,150 (2,850 )
At 31 March 2022 42,638 65,341 107,979

9. RELATED PARTY DISCLOSURES

One of the properties sub-let by the company is rented from Seema Luthra, the daughter of Mr and Mrs Luthra, on a full repairing and insuring lease at a nominal rental of £12 per annum.

A & S Medical Services Ltd (Registered number: SC261160)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

10. ULTIMATE CONTROLLING PARTY

The company was under the control of the directors, Dr & Mrs Luthra, throughout the year. Dr and Mrs Luthra jointly own 100% of the company's issued share capital.